Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases

doi:10.1084/jem.171.2.449

This Article

Full Text (PDF, 409K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Walz, A.

Articles by Baggiolini, M.

Search for Related Content

PubMed

PubMed Citation

Articles by Walz, A.

Articles by Baggiolini, M.

Pubmed/NCBI databases

Gene	GEO Profiles
HomoloGene	Protein
UniGene
Substance via MeSH

Social Bookmarking

What's this?

ARTICLES

Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases

A Walz and M Baggiolini
Theodor-Kocher Institute, University of Bern, Switzerland.

We studied the origin of the neutrophil-activating peptide NAP-2, a presumed 70 amino acid cleavage product of platelet basic protein (PBP) and connective tissue-activating peptide III (CTAP-III). Purified human blood monocytes or lymphocytes were cultured with or without stimuli (LPS or PHA) in the presence or absence of platelet-release supernatant, and the formation of NAP-2 and other neutrophil-activating peptides was monitored. NAP-2 was generated whenever monocytes and platelet release supernatant were present. When a monocyte stimulus was added, NAF/NAP-1 was also formed, and in the presence of LPS a third, less potent neutrophil-stimulating fraction, consisting of NAP-2 variants with 73, 74, and 75 residues, also appeared. Monocytes alone did not yield NAP-2 and no neutrophil-activating peptide was generated by lymphocytes. The monocyte-conditioned medium was found to cleave purified CTAP-III into NAP-2 through proteinases that were highly sensitive to PMSF, moderately sensitive to leupeptin and insensitive to EDTA.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Proost, P., Mortier, A., Loos, T., Vandercappellen, J., Gouwy, M., Ronsse, I., Schutyser, E., Put, W., Parmentier, M., Struyf, S., Van Damme, J. (2007). Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 110: 37-44 [Abstract] [Full Text]
Aivado, M., Spentzos, D., Germing, U., Alterovitz, G., Meng, X.-Y., Grall, F., Giagounidis, A. A. N., Klement, G., Steidl, U., Otu, H. H., Czibere, A., Prall, W. C., Iking-Konert, C., Shayne, M., Ramoni, M. F., Gattermann, N., Haas, R., Mitsiades, C. S., Fung, E. T., Libermann, T. A. (2007). From the cover: Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proc. Natl. Acad. Sci. USA 104: 1307-1312 [Abstract] [Full Text]
Smith, C., Damas, J. K., Otterdal, K., Oie, E., Sandberg, W. J., Yndestad, A., Waehre, T., Scholz, H., Endresen, K., Olofsson, P. S., Halvorsen, B., Gullestad, L., Froland, S. S., Hansson, G. K., Aukrust, P. (2006). Increased Levels of Neutrophil-Activating Peptide-2 in Acute Coronary Syndromes: Possible Role of Platelet-Mediated Vascular Inflammation. J Am Coll Cardiol 48: 1591-1599 [Abstract] [Full Text]
Schiemann, F., Grimm, T. A., Hoch, J., Gross, R., Lindner, B., Petersen, F., Bulfone-Paus, S., Brandt, E. (2006). Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G. Blood 107: 2234-2242 [Abstract] [Full Text]
Schaffner, A., King, C. C., Schaer, D., Guiney, D. G. (2004). Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes. J. Leukoc. Biol. 76: 1010-1018 [Abstract] [Full Text]
Rennen, H. J.J.M., Frielink, C., Brandt, E., Zaat, S. A.J., Boerman, O. C., Oyen, W. J.G., Corstens, F. H.M. (2004). Relationship Between Neutrophil-Binding Affinity and Suitability for Infection Imaging: Comparison of 99mTc-Labeled NAP-2 (CXCL-7) and 3 C-Terminally Truncated Isoforms. JNM 45: 1217-1223 [Abstract] [Full Text]
El-Gedaily, A., Schoedon, G., Schneemann, M., Schaffner, A. (2004). Constitutive and regulated expression of platelet basic protein in human monocytes. J. Leukoc. Biol. 75: 495-503 [Abstract] [Full Text]
Nassar, T., Sachais, B. S., Akkawi, S.'e., Kowalska, M. A., Bdeir, K., Leitersdorf, E., Hiss, E., Ziporen, L., Aviram, M., Cines, D., Poncz, M., Higazi, A. A.-R. (2003). Platelet Factor 4 Enhances the Binding of Oxidized Low-density Lipoprotein to Vascular Wall Cells. J. Biol. Chem. 278: 6187-6193 [Abstract] [Full Text]
Schenk, B. I., Petersen, F., Flad, H.-D., Brandt, E. (2002). Platelet-Derived Chemokines CXC Chemokine Ligand (CXCL)7, Connective Tissue-Activating Peptide III, and CXCL4 Differentially Affect and Cross-Regulate Neutrophil Adhesion and Transendothelial Migration. J. Immunol. 169: 2602-2610 [Abstract] [Full Text]
Malawista, S. E., Van Damme, J., Smallwood, J. I., de Boisfleury Chevance, A. (2002). Chemotactic activity of human blood leukocytes in plasma treated with EDTA: chemoattraction of neutrophils about monocytes is mediated by the generation of NAP-2. J. Leukoc. Biol. 72: 175-182 [Abstract] [Full Text]
McQuibban, G. A., Butler, G. S., Gong, J.-H., Bendall, L., Power, C., Clark-Lewis, I., Overall, C. M. (2001). Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1. J. Biol. Chem. 276: 43503-43508 [Abstract] [Full Text]
Clemetson, K. J., Clemetson, J. M., Proudfoot, A. E. I., Power, C. A., Baggiolini, M., Wells, T. N. C. (2000). Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 96: 4046-4054 [Abstract] [Full Text]
Ehlert, J. E., Ludwig, A., Grimm, T. A., Lindner, B., Flad, H.-D., Brandt, E. (2000). Down-regulation of neutrophil functions by the ELR+ CXC chemokine platelet basic protein. Blood 96: 2965-2972 [Abstract] [Full Text]
Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., Opdenakker, G. (2000). Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96: 2673-2681 [Abstract] [Full Text]
Krijgsveld, J., Zaat, S. A. J., Meeldijk, J., van Veelen, P. A., Fang, G., Poolman, B., Brandt, E., Ehlert, J. E., Kuijpers, A. J., Engbers, G. H. M., Feijen, J., Dankert, J. (2000). Thrombocidins, Microbicidal Proteins from Human Blood Platelets, Are C-terminal Deletion Products of CXC Chemokines. J. Biol. Chem. 275: 20374-20381 [Abstract] [Full Text]
Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., Power, C. A. (2000). International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors. Pharmacol. Rev. 52: 145-176 [Abstract] [Full Text]
Shimoya, K., Moriyama, A., Matsuzaki, N., Ogata, I., Koyama, M., Azuma, C., Saji, F., Murata, Y. (1999). Human placental cells show enhanced production of interleukin (IL)-8 in response to lipopolysaccharide (LPS), IL-1 and tumour necrosis factor (TNF)-{alpha}, but not to IL-6. Mol Hum Reprod 5: 885-885 [Abstract] [Full Text]
Chung, K F, Barnes, P J (1999). Cytokines in asthma. Thorax 54: 825-857 [Full Text]
Wakasugi, K., Schimmel, P. (1999). Highly Differentiated Motifs Responsible for Two Cytokine Activities of a Split Human tRNA Synthetase. J. Biol. Chem. 274: 23155-23159 [Abstract] [Full Text]
Wakasugi, K., Schimmel, P. (1999). Two Distinct Cytokines Released from a Human Aminoacyl-tRNA Synthetase. Science 284: 147-151 [Abstract] [Full Text]
Barnes, P. J., Chung, K. F., Page, C. P. (1998). Inflammatory Mediators of Asthma: An Update. Pharmacol. Rev. 50: 515-596 [Abstract] [Full Text]
Goodman, R. B., Strieter, R. M., Frevert, C. W., Cummings, C. J., Tekamp-Olson, P., Kunkel, S. L., Walz, A., Martin, T. R. (1998). Quantitative comparison of C-X-C chemokines produced by endotoxin-stimulated human alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 275: L87-L95 [Abstract] [Full Text]
Ludwig, A., Petersen, F., Zahn, S., Gotze, O., Schroder, J.-M., Flad, H.-D., Brandt, E. (1997). The CXC-Chemokine Neutrophil-Activating Peptide-2 Induces Two Distinct Optima of Neutrophil Chemotaxis by Differential Interaction With Interleukin-8 Receptors CXCR-1 and CXCR-2. Blood 90: 4588-4597 [Abstract] [Full Text]
Pal, R., Garzino-Demo, A., Markham, P. D., Burns, J., Brown, M., Gallo, R. C., DeVico, A. L. (1997). Inhibition of HIV-1 Infection by the $beta$ -Chemokine MDC. Science 278: 695-698 [Abstract] [Full Text]
Malkowski, M. G., Wu, J. Y., Johnson, P. H., Edwards, B. F. P. (1995). The Crystal Structure of Recombinant Human Neutrophil-activating Peptide-2 (M6L) at 1.9-� Resolution. J. Biol. Chem. 270: 7077-7087 [Abstract] [Full Text]
Ehlert, J. E., Petersen, F., Kubbutat, M. H. G., Gerdes, J., Flad, H.-D., Brandt, E. (1995). Limited and Defined Truncation at the C Terminus Enhances Receptor Binding and Degranulation Activity of the Neutrophil-activating Peptide 2 (NAP-2). J. Biol. Chem. 270: 6338-6344 [Abstract] [Full Text]
Wakefield, T. W., Strieter, R. M., Wilke, C. A., Kadell, A. M., Wrobleski, S. K., Burdick, M. D., Schmidt, R., Kunkel, S. L., Greenfield, L. J. (1995). Venous Thrombosis�Associated Inflammation and Attenuation With Neutralizing Antibodies to Cytokines and Adhesion Molecules. Arterioscler. Thromb. Vasc. Bio. 15: 258-268 [Abstract] [Full Text]
Stoeckelhuber, M., Dobner, P., Baumgartner, P., Ehlert, J., Brandt, E., Mentele, R., Adam, D., Engelmann, B. (2000). Stimulation of Cellular Sphingomyelin Import by the Chemokine Connective Tissue-activating Peptide III. J. Biol. Chem. 275: 37365-37372 [Abstract] [Full Text]